Anaplastic Lymphoma Kinase in Cutaneous Malignancies
Anaplastic lymphoma kinase (ALK) is a receptor tyrosine kinase that has been implicated in the pathogenesis of a variety of neoplasms. As suggested by its name, ALK was first described as part of a translocation product in cases of anaplastic large-cell lymphoma, with other genetic and cytogenetic A...
Main Authors: | Severine Cao, Vinod E. Nambudiri |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2017-09-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/9/9/123 |
Similar Items
-
Three years sustained complete remission achieved in a primary refractory ALK-positive anaplastic T large cell lymphoma treated with crizotinib
by: Carolina Valeria Mahuad, et al.
Published: (2016-06-01) -
Primary Cutaneous Anaplastic Large-Cell Lymphoma
by: Nerissa Moodley, et al.
Published: (2019-06-01) -
A case of tonsillar anaplastic large cell lymphoma-anaplastic lymphoma kinase negative: An unusual site of involvement with review of literature
by: Umesh Das, et al.
Published: (2014-01-01) -
Anaplastic lymphoma kinase negative anaplastic large cell lymphoma of hard palate as first clinical manifestation of acquired immune deficiency syndrome
by: Anjali Narwal, et al.
Published: (2016-01-01) -
A primary retroperitoneal anaplastic lymphoma kinase-positive anaplastic large cell lymphoma with tumor thrombosis
by: Li J, et al.
Published: (2018-12-01)